News | January 15, 2013

Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta

radiation therapy

January 14, 2013 — Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for radiation therapy of partial breast and Elekta a global leader in cancer management systems and software, announced today that they have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner. As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S. The transaction is designed to enable both companies to focus on their core competencies, and serves AccuBoost user groups by allowing ART to increase its support to these installations.

Piran Sioshansi, Ph.D., President and CEO of ART, stated: "The support of Nucletron/Elekta has been helpful for the growth of the AccuBoost product to become an established treatment option for partial breast radiation therapy in the United States. With this agreement, AccuBoost will resume its lead position in support of the treatment centers and concentrate on future growth of the technology and accelerate the introduction of new treatment options."

"AccuBoost is well positioned to enter into a stage of substantial growth," Dr. Sioshansi continued, "and plans to hire additional staff and work independently with all of the providers in the radiation oncology marketplace."

Bill Dowd, Vice President, Brachytherapy, North America with Nucletron, an Elekta Company, stated: "We believe this is the best way forward for the development of AccuBoost and for customers using this solution."

The AccuBoost procedure is designed for women diagnosed with early stage breast cancer who pursue Breast Conserving Therapy (BCT). AccuBoost is a new brachytherapy modality that uses real time image guidance to target the radiation dose for patients who choose BCT. The mammography image-guided AccuBoost partial breast irradiation procedure is offered either for breast boost therapy, as part of the course of whole breast irradiation regimen or as a non-invasive monotherapy option for Accelerated Partial Breast Irradiation (APBI).

For more information: www.artcorporation.net

Related Content

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...